Daily Stock Analysis, BCR, C R Bard Inc, priceseries

C R Bard Inc. Daily Stock Analysis
Stock Information
Open
332.94
Close
334.50
High
335.34
Low
332.31
Previous Close
332.10
Daily Price Gain
2.40
YTD High
337.73
YTD High Date
Dec 1, 2017
YTD Low
223.69
YTD Low Date
Jan 3, 2017
YTD Price Change
107.66
YTD Gain
47.46%
52 Week High
337.73
52 Week High Date
Dec 1, 2017
52 Week Low
218.11
52 Week Low Date
Dec 22, 2016
52 Week Price Change
114.08
52 Week Gain
51.76%
Company Information
Stock Symbol
BCR
Exchange
NYSE
Company URL
http://www.crbard.com
Company Phone
9082778000
CEO
Timothy M. Ring
Headquarters
New Jersey
Business Address
730 CENTRAL AVE, MURRAY HILL, NJ 07974
Sector
Equity
Industry Category
Health Services
Industry Group
Medical Instruments & Supplies
CIK
0000009892
About

C.R. Bard, Inc. designs, develops, manufactures, distributes and markets medical technologies in the fields of vascular, urology, oncology and surgical specialty products. It sells a range of products to hospitals, individual healthcare professionals, extended care facilities and alternate site facilities. The company was founded by Charles Russell Bard in 1907 and is headquartered in Murray Hill, NJ.

Description

C. R. Bard, Inc., together with its subsidiaries, designs, manufactures, packages, distributes, and sells medical, surgical, diagnostic, and patient care devices worldwide. The company offers vascular products, such as percutaneous transluminal angioplasty catheters, chronic total occlusion catheters, guidewires, fabrics, meshes, introducers, and accessories; valvuloplasty balloons; peripheral vascular stents, self-expanding and balloon-expandable covered stents, and vascular grafts; vena cava filters; biopsy devices; and a range of minimally invasive devices for the treatment of peripheral vascular and end-stage renal diseases. It also provides urology products, including Foley catheters to reduce the rate of urinary tract infections; fecal incontinence products; brachytherapy devices and radioactive seeds for the treatment of prostate cancer; intermittent urinary drainage catheters, and urine monitoring and collection systems; ureteral stents; specialty devices for stone removal procedures; surgical slings and pelvic floor repair products; catheter stabilization devices; and products for therapeutic hypothermia. In addition, the company offers oncology products, such as specialty vascular access catheters and ports, vascular access ultrasound devices, dialysis access catheters, and enteral feeding devices to treat and manage various cancers, and other diseases and disorders. Further, it provides surgical specialty products comprising implanted grafts and fixation devices for hernia and soft tissue repairs; and hemostats and surgical sealants, as well as irrigation, wound drainage, and original equipment manufacturers' products. The company sells its products directly to hospitals, individual healthcare professionals, extended care facilities, and alternate site facilities through hospital/surgical supply and other medical specialty distributors. C. R. Bard, Inc. was founded in 1907 and is headquartered in Murray Hill, New Jersey.